solid tumor
Showing 9976 - 10000 of >10,000
Carcinoma, Hepatocellular Trial in United States (Everolimus, Tacrolimus, Myfortic)
Active, not recruiting
- Carcinoma, Hepatocellular
- Everolimus
- +4 more
-
San Francisco, California
- +8 more
Jul 19, 2022
Head Neck Cancer Trial in United States (fluorine-18-labeled fluoro-misonidazole (18F-FMISO), 18F-FMISO PET scan, MRI)
Active, not recruiting
- Head and Neck Cancer
- fluorine-18-labeled fluoro-misonidazole (18F-FMISO)
- +3 more
-
Basking Ridge, New Jersey
- +4 more
Jul 8, 2022
Recurrent Low Grade Astrocytoma, Recurrent WHO Grade 2 Glioma, Refractory Low Grade Astrocytoma Trial in Canada, United States
Recruiting
- Recurrent Low Grade Astrocytoma
- +4 more
- Quality-of-Life Assessment
- +3 more
-
Birmingham, Alabama
- +64 more
Aug 20, 2022
Glioblastoma Trial (New delineation approach)
Not yet recruiting
- Glioblastoma
- New delineation approach
- (no location specified)
Aug 22, 2022
Colorectal Cancer, Liver Metastases Trial in Belgium, Netherlands (FOLFOX/ FOLFIRI with bevacizumab, FOLFOXIRI with bevacizumab,
Recruiting
- Colorectal Cancer
- Liver Metastases
- FOLFOX/ FOLFIRI with bevacizumab
- +2 more
-
Antwerpen, Belgium
- +65 more
Mar 24, 2022
Organ Transplant, Immunosuppression Trial in Toronto (7-valent pneumococcal conjugate vaccine, Pneumococcal 7-valent Conjugate
Completed
- Organ Transplant
- Immunosuppression
- 7-valent pneumococcal conjugate vaccine
- Pneumococcal 7-valent Conjugate Vaccine
-
Toronto, Ontario, CanadaThe Hospital for Sick Children
Feb 10, 2021
Comprehensive Genomic Profiling Combined With Real Life Data of
Active, not recruiting
- Gallbladder Carcinoma
-
Frankfurt am Main, GermanyInstitut für Klinische Krebsforschung IKF GmbH
Jan 31, 2022
NSCLC Trial in Tübingen, Münich, Heidelberg (Photons)
Recruiting
- Non-small Cell Lung Cancer
- Photons
-
Tübingen, Baden-Württemberg, Germany
- +2 more
Aug 19, 2022
Quality of Life Trial in Belgium (EORTC QLQ-C30, EORTC QLQ-GI.NET21, Satisfaction survey)
Recruiting
- Quality of Life
- EORTC QLQ-C30
- +2 more
-
Brasschaat, Antwerp, Belgium
- +6 more
Mar 8, 2022
T Cell Lymphoma, T-cell Leukemia Trial in Beijing (Efficacy of LCAR-T2C CAR-T cells)
Terminated
- T Cell Lymphoma
- T-cell Leukemia
- Efficacy of LCAR-T2C CAR-T cells
-
Beijing, Beijing, China
- +1 more
Aug 12, 2022
Circulating Tumor DNA in Colorectal Cancer Undergoing
Not yet recruiting
- Metastatic Colorectal Cancer
- Circulating Tumor DNA
-
Besançon, France
- +15 more
Mar 24, 2023
Intra-operative Image Guidance System for Missing Metastases
Active, not recruiting
- Colorectal Cancer
- Metastatic to the Liver
- (no location specified)
Jun 14, 2022
Prostate Cancer Trial in Canada, United States (bicalutamide, radiation therapy, )
Glioblastoma Multiforme, Glioma of Brain Trial in Chandler, Phoenix, Scottsdale (Ribociclib, Everolimus)
Completed
- Glioblastoma Multiforme
- Glioma of Brain
-
Chandler, Arizona
- +2 more
Jan 11, 2023
Pancreatic Cancer, Advanced Pancreatic Ductal Adenocarcinoma Trial in United States (Gemcitabine, Nab-paclitaxel, PEGPH20)
Active, not recruiting
- Pancreatic Cancer
- Advanced Pancreatic Ductal Adenocarcinoma
- Gemcitabine
- +2 more
-
Hartford, Connecticut
- +9 more
Jul 15, 2022
Carcinoid Tumor, Pancreatic Neuroendocrine Tumor Trial in Boston (Cabozantinib)
Active, not recruiting
- Carcinoid Tumor
- Pancreatic Neuroendocrine Tumor
-
Boston, Massachusetts
- +1 more
Jul 15, 2022
Growth Parameters & Body Mass Index in Chronic Diseases
Not yet recruiting
- Chronic Medical Diseases
- Growth parameters & body mass index
-
Sohag, EgyptSohag University Hospital
Mar 26, 2023
Common Bile Duct in Obstructive Jaundice Due to Bilio-pancreatic
Completed
- Obstructive Jaundice
- Bilio-pancreatic Tumor
- Ultrasound endoscopy
-
Lyon, FranceHôpital Jean Mermoz
Nov 30, 2021
Gastric Adenocarcinoma, Esophageal Cancer, Hepatocellular Carcinoma Trial in United States (Sacituzumab Govitecan-hziy (SG))
Completed
- Gastric Adenocarcinoma
- +15 more
- Sacituzumab Govitecan-hziy (SG)
-
Aurora, Colorado
- +11 more
Aug 10, 2021
Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IIIC Lung Cancer AJCC v8 Trial in
Recruiting
- Metastatic Lung Non-Small Cell Carcinoma
- +3 more
- Biopsy
- +6 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 9, 2023
Recurrent DLBCL, Refractory DLBCL Trial in Houston (Chemotherapy, Computed Tomography, Fludeoxyglucose F-18)
Completed
- Recurrent Diffuse Large B-Cell Lymphoma
- Refractory Diffuse Large B-Cell Lymphoma
- Chemotherapy
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Oct 27, 2022
Subjects Previously Enrolled on NCI Surgery Branch Studies
Enrolling by invitation
- Melanoma
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 18, 2022